You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dose expansion

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor Trial (STI-7349, Pembrolizumab)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Aug 3, 2023

Unresectable or Metastatic Advanced Solid Tumors Trial (WTX212A)

Not yet recruiting
  • Unresectable or Metastatic Advanced Solid Tumors
  • (no location specified)
Sep 6, 2023

Non-muscle Invasive Bladder Cancer Trial (TARA-002)

Not yet recruiting
  • Non-muscle Invasive Bladder Cancer
  • TARA-002
  • (no location specified)
Jul 14, 2023

Metastatic Castration-resistant Prostate Cancer Trial (HP518 - Dose Escalation, HP518 -Dose Expansion)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • HP518 - Dose Escalation
  • HP518 -Dose Expansion
  • (no location specified)
Dec 1, 2023

Advanced Solid Tumor Trial (NB002)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Jun 29, 2023

Solid Advanced Tumor, Lymphoma Trial in Belgium, France (OSE-279 100mg, OSE-279 300mg, OSE-279 500mg)

Recruiting
  • Solid Advanced Tumor
  • Lymphoma
  • OSE-279 100mg
  • +2 more
  • Anderlecht, Belgium
  • +5 more
Feb 27, 2023

Advanced Solid Tumors Trial in Beijing (WJB001)

Not yet recruiting
  • Advanced Solid Tumors
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Mar 15, 2023

Myeloid Diseases Trial (DFV890)

Not yet recruiting
  • Myeloid Diseases
  • (no location specified)
Nov 11, 2022

AML, Adult Trial (STI-8591)

Not yet recruiting
  • AML, Adult
  • (no location specified)
Jul 12, 2023

Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC) Trial (PT217)

Not yet recruiting
  • Small Cell Lung Cancer (SCLC)
  • +3 more
  • (no location specified)
Dec 7, 2022

Advanced Malignant Solid Tumor, RAS Mutation, Lung Cancer Trial in United States (RSC-1255 Dose Escalation, RSC-1255 Dose

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +5 more
  • RSC-1255 Dose Escalation
  • RSC-1255 Dose Expansion
  • Los Angeles, California
  • +5 more
Oct 24, 2022

Tumors Malignant Trial in Shanghai (AK117)

Active, not recruiting
  • Neoplasms Malignant
  • Shanghai, Shanghai, China
    FuDan University Shanghai Cancer Center
Oct 8, 2022

NSCLC Trial in Omaha (PLB1004)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Omaha, Nebraska
    Nebraska Cancer Specialists
Sep 19, 2023

Rett Syndrome Trial (TSHA-102)

Not yet recruiting
  • Rett Syndrome
  • TSHA-102
  • (no location specified)
Nov 21, 2023

Solid Tumor, Adult, Non-hodgkin Lymphoma, Hodgkin Lymphoma Trial in India (AUR105)

Recruiting
  • Solid Tumor, Adult
  • +2 more
  • Vadodara, Gujarat, India
  • +6 more
Dec 14, 2022

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Tampa (Fludarabine, Cyclophosphamide,

Recruiting
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 12, 2023

Breast Cancer, Solid Tumors Trial in Boston, Grand Rapids, Houston (PF-07220060 + PF-07104091 combination dose escalation,

Recruiting
  • Breast Cancer
  • Solid Tumors
  • PF-07220060 + PF-07104091 combination dose escalation
  • +2 more
  • Grand Rapids, Michigan
  • +1 more
Jun 28, 2022

HER-2 Positive Advanced Solid Tumors Trial (D3L-001)

Not yet recruiting
  • HER-2 Positive Advanced Solid Tumors
  • D3L-001
  • (no location specified)
Jul 20, 2023

Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)

Not yet recruiting
  • Triple Negative Breast Cancer
  • +13 more
  • (no location specified)
Aug 29, 2023

Light Chain (AL) Amyloidosis Trial in Sacramento (NXC-201 CAR-T)

Not yet recruiting
  • Light Chain (AL) Amyloidosis
  • NXC-201 CAR-T
  • Sacramento, California
    University of California Davis Medical Center
Oct 19, 2023

Cancer, Solid Tumor, Melanoma Trial (KVA12123 - Dose Escalation, KVA12123 Plus Pembrolizumab - Dose Escalation, KVA12123 - Dose

Not yet recruiting
  • Cancer
  • +16 more
  • KVA12123 - Dose Escalation
  • +3 more
  • (no location specified)
Feb 2, 2023

Solid Tumor Trial in Hackensack (SAR445877)

Recruiting
  • Solid Tumor
  • Hackensack, New Jersey
    John Theurer Cancer Center-Site Number:8400001
Dec 8, 2022

Solid Tumor, Adult Trial (CF33-CD19 IT, CF33-CD19 IV, Blinatumomab)

Not yet recruiting
  • Solid Tumor, Adult
  • CF33-CD19 IT
  • +2 more
  • (no location specified)
Sep 26, 2023

Solid Tumor Trial in Port Saint Lucie (ALG.APV-527)

Recruiting
  • Solid Tumor
  • Port Saint Lucie, Florida
    Hematology Oncology Associates Of The Treasure Coast
Jun 28, 2023

NSCLC (NSCLC), Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma Trial in Nashville, San Antonio, Fairfax (RMC-6291)

Recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • +3 more
  • San Antonio, Texas
  • +1 more
Aug 16, 2022